Testosterone is men's health podcasting's main character. Whether the episode is about energy, muscle, mood or aging, it bends toward one question: is testosterone replacement therapy (TRT) an under-used medical treatment or an over-sold lifestyle drug? Four shows carry most of the conversation, and they answer it differently.
How one hormone became a cultural symbol
Real trends fed the worry. The most cited data, the Massachusetts Male Aging Study analyses, found average testosterone levels falling by roughly one percent a year, independent of age. Suspects include rising obesity, environmental exposures and chronic sleep loss (a thread our guide to sleep podcasts follows). Meta-analyses reporting falling sperm counts, still scientifically contested, added fuel.
Then online men's clinics turned hormone care into e-commerce: a mailed blood panel, a video consult, vials by post. Podcasts discussed all of it, and ran the ads. An Epic Research analysis published in July 2026 found that testosterone prescribing bottomed out in 2021 and then climbed until, by 2025, every age group from 30 up had passed its early-2010s peak. Physicians on the medical shows worry most about men in their twenties and thirties with normal labs, who have the most to lose from treatment they never needed. The same clinics turn up across the podcasts tracking the telehealth boom.
The four shows side by side
Two shows come at testosterone from medicine: The Peter Attia Drive and Huberman Lab. Two come from bodybuilding and strength sports, where use is common and openly discussed: More Plates More Dates and Mark Bell's Power Project.
| Show | Stance on TRT | Strongest episodes and guests | Blind spot |
|---|---|---|---|
| The Peter Attia Drive | Medicine with trade-offs; a long commitment too often started casually | #260, urologist Mohit Khera; #310, Ted Schaeffer on prostate cancer and TRAVERSE; #351, Paul Turek on male fertility | Assumes you can pay for labs and specialists |
| Huberman Lab | Lifestyle first, pharmacology last | Dr. Kyle Gillett (April and December 2022); Stanford urologist Dr. Michael Eisenberg on fertility (November 2023) | Protocol detail sometimes runs ahead of the trial evidence |
| More Plates More Dates | Literate, optimization-friendly | TRT dosing with Peter Attia (June 2024); "Being On TRT vs. Being On 'TRT'" (January 2025) | Host runs supplement businesses; audience leans toward enhancement |
| Mark Bell's Power Project | Candid about use in strength sports | "Your TRT User Manual" with Ali Gilbert (2023); "Beginner's Guide to TRT" (July 2025) | Anecdote-heavy |
Attia's framing is the sober baseline. His episodes define "low T" as symptoms plus repeated morning labs (a single afternoon reading proves little) and separate treating a deficiency from chasing a feeling. Fertility keeps coming up, because young men underestimate it: testosterone from outside the body shuts down sperm production. On the heart, the large TRAVERSE trial (NEJM, 2023) found testosterone noninferior to placebo for major cardiac events in men aged 45 to 80 with hypogonadism and raised cardiovascular risk. That reassures the men it studied and says nothing about recreational use; the testosterone group also had more atrial fibrillation, acute kidney injury and pulmonary embolism.
Huberman supplies the mechanism. In the Gillett conversations, sleep, body composition, training and micronutrients come first because they move testosterone before any prescription does. The Eisenberg episode covers the collision between TRT and fertility and the alternatives (hCG, clomiphene-style protocols) a clinic's checkout flow rarely mentions. The message: pharmacology last, and only once you know what it forecloses.
Derek, the creator behind More Plates More Dates, covers protocols, ancillary drugs, blood work and bodybuilding pharmacology in a depth no medical show attempts. His two conversations on The Drive (#274 and #291, 2023 and 2024), plus Attia's visits to his channel, are the best bridge between the medical and enthusiast worlds. Mark Bell's Power Project says more plainly than polite media how widespread use is. The literacy on both shows is real, and so is the selection effect: these audiences skew toward optimization over deficiency, as the better episodes admit.
The prescribing boom behind the episodes
For men with confirmed hypogonadism TRT works, and the serious shows say so. Their argument is about the prescribing boom. The access side: middle-aged men with real symptoms were long dismissed, or never visited a clinic, and a mailed blood panel plus a video call closed that gap. The medical shows press the other side: demand created by marketing, men in their twenties with normal labs starting a drug they may take for life, and clinics whose revenue depends on a yes.
How online men's health clinics work, and what to check
Most online clinics follow the same path: a questionnaire, a blood test at home or at a partner lab, a video consult, then medication shipped on a monthly plan. They differ in what the plan includes. Some bundle follow-up labs and regular consults, others charge for them separately. Some offer only injections, others gels or creams, and some add hCG or similar drugs meant to protect fertility. Before signing up, check that the prescriber is licensed where you live and that the clinic asks for two morning tests before any prescription. Ask how often it will check your red blood cell count and PSA, the monitoring that guidelines call for, and who answers when side effects appear. Ask what stopping would look like and whether results can go to your own doctor. These are the questions the medical guests on Attia and Huberman raise, and the same clinics often buy ad time on the shows that discuss them.
What the careful shows agree on
Under the arguing, both sides share a checklist:
- Get real blood work twice, in the morning, before believing anything about your hormones.
- Symptoms plus repeatedly low numbers justify a medical conversation. Normal numbers plus ambition call for a training plan.
- Sleep, body composition and strength training come first, every time.
- Talk about fertility before the first dose; skipping that conversation is a failure by clinic and podcast alike.
- Expect a long commitment. After years of suppression, natural production can take many months to return, and in some men it never fully does, so the decision needs an ongoing relationship with a physician.
- Low mood, fatigue and anxiety have many causes besides hormones; see our list of mental health podcasts for anxiety.
A listening path by age and situation
- Under 40, or planning to have children: start with Huberman's Eisenberg episode, then Attia's #351 with Paul Turek. They explain what TRT does to fertility and the alternatives.
- 45 or older with symptoms: Attia's #260 with Mohit Khera for diagnosis and treatment, then #310 with Ted Schaeffer for the prostate and TRAVERSE questions.
- Already talking to an online clinic: Huberman's "Tools for Hormone Optimization in Males" with Gillett (December 2022), so you know what to try first and what to ask.
- Curious about the optimization world: Attia's #274 with Derek, then one More Plates More Dates deep dive, to see what enthusiasts actually do.
Whichever line fits, take what you learn to a doctor who will order the repeat morning labs. The podcasts explain the trade-offs; the prescription is a decision for you and that doctor.
The shows referenced appear in Reason.fm's Health & Fitness, Fitness and Medicine charts.
This article looks at how podcasts discuss the topic and is not medical advice. Talk to a doctor or other qualified clinician about your own situation before starting, changing or stopping any treatment.